AMALGAMATED BANK - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8
-55.6%
13,7070.0%0.00%
Q2 2023$18
-30.8%
13,707
-6.1%
0.00%
Q1 2023$26
-50.9%
14,597
-13.2%
0.00%
Q4 2022$53
-99.9%
16,821
+4.3%
0.00%
-100.0%
Q3 2022$79,000
+25.4%
16,128
+5.5%
0.00%0.0%
Q2 2022$63,000
-42.2%
15,289
-18.7%
0.00%0.0%
Q1 2022$109,000
-64.4%
18,807
-53.9%
0.00%0.0%
Q4 2021$306,000
+64.5%
40,768
+98.0%
0.00%
-50.0%
Q3 2021$186,000
-28.2%
20,594
-4.7%
0.00%0.0%
Q2 2021$259,000
+26.3%
21,611
+32.1%
0.00%
-75.0%
Q1 2021$205,000
-27.0%
16,364
-9.1%
0.01%
-27.3%
Q4 2020$281,000
+66.3%
17,993
+0.5%
0.01%
+57.1%
Q3 2020$169,000
+3.0%
17,905
-2.5%
0.01%
-12.5%
Q2 2020$164,000
+31.2%
18,357
-6.7%
0.01%
+166.7%
Q1 2020$125,000
-26.0%
19,675
-2.6%
0.00%0.0%
Q4 2019$169,000
-3.4%
20,197
+4.2%
0.00%
-25.0%
Q3 2019$175,000
-16.7%
19,380
-0.6%
0.00%
-20.0%
Q2 2019$210,000
+41.9%
19,506
+25.5%
0.01%
+25.0%
Q1 2019$148,000
-14.0%
15,548
+3.7%
0.00%
-20.0%
Q4 2018$172,000
-21.8%
14,999
-3.1%
0.01%0.0%
Q2 2018$220,000
+3.8%
15,478
+38.4%
0.01%
-16.7%
Q1 2018$212,000
+12.8%
11,184
-2.3%
0.01%
+20.0%
Q4 2017$188,000
+19.0%
11,443
+8.5%
0.01%0.0%
Q3 2017$158,00010,5500.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders